← Back to Search

Behavioural Intervention

Digital Clinic for Alcoholism and Liver Disease (DALC Trial)

N/A
Recruiting
Led By Douglas Simonetto, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if using a digital clinic with multiple specialists can help improve health outcomes, lower costs, increase access to care, and make healthcare providers happier. The main goal is to improve outcomes

Who is the study for?
This trial is for individuals with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). It's designed to see if a digital clinic can help improve their health outcomes. Participants should be comfortable using digital tools for treatment.
What is being tested?
The DALC Digital Clinic, a multidisciplinary online platform, is being tested to see if it can enhance the care of patients with ALD and AUD by improving health results, reducing costs, increasing access to care, and boosting satisfaction for both providers and patients.
What are the potential side effects?
Since this trial involves the use of a digital clinic rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience issues related to technology use such as eye strain or stress from learning new tools.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Median delta MELD-3.0 from baseline to end of study.
Secondary study objectives
Greater provider satisfaction in DALC arm
Reduction of Number of hospitalizations
Sustained alcohol abstinence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Clinic ArmExperimental Treatment1 Intervention
The Ria Treatment Platform (RTP) application will be downloaded onto the patient's smart phone or tablet.
Group II: Standard of Care ArmActive Control1 Intervention
Primary care providers will treat subject per standard of care utilizing the Interactive Care Plan program.

Find a Location

Who is running the clinical trial?

Ria HealthIndustry Sponsor
1 Previous Clinical Trials
124 Total Patients Enrolled
1 Trials studying Alcoholism
124 Patients Enrolled for Alcoholism
Mayo ClinicLead Sponsor
3,343 Previous Clinical Trials
3,062,309 Total Patients Enrolled
8 Trials studying Alcoholism
1,536 Patients Enrolled for Alcoholism
Douglas Simonetto, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
450 Total Patients Enrolled
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top